Navigation Links
Alseres and BioAxone Amend License Agreement for Cethrin(R) and Rho Inhibitor Technology
Date:4/30/2009

s, Chairman and CEO of Alseres. Mr. Savas continued: "We are deeply committed to the continued clinical development of Cethrin to treat patients with acute spinal cord injury. In the current environment, we believe that finding a strong development and commercialization partner for Cethrin is the best path forward to ensure that it is developed in a focused, efficient manner while Alseres concentrates on advancing Altropane toward market approval in the U.S. The amended agreement enables Alseres and BioAxone to work together on this partnering effort without the distraction of an arbitration procedure."

Cethrin License Background

In December 2006, the Company entered into the Cethrin License (as amended in March 2007), pursuant to which the Company was granted an exclusive, worldwide license to develop and commercialize specified compounds including, but not limited to, Cethrin, as further defined in the Cethrin License. The Cethrin License called for the Company to conduct development and commercialization activities of Cethrin and to pay certain pre-commercialization milestones and on-going royalties on sales of Cethrin when and if approved for marketing. The Amendment changes the pre-commercialization milestones and on-going royalty terms to an income-sharing approach.

About Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc. (ALSE) is engaged in the development of diagnostic and therapeutic products primarily for disorders in the central nervous system (CNS). The Company has a robust molecular imaging development program targeting diagnosis of Parkinsonian Syndromes and potentially dementia. The Company's lead molecular imaging product candidate is Altropane which is in Phase III clinical trials for the diagnosis of Parkinsonian Syndromes including Parkinson's disease. The Company maintains a world-class intellectual property position in the field of regenerative therapeuti
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
2. Alseres Pharmaceuticals, Inc. Raises $5 Million
3. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
4. Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
5. Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call
6. Alseres Pharmaceuticals, Inc. Reports First Quarter 2008 Operational and Financial Results
7. Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)
8. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
9. Alseres Pharmaceuticals, Inc.s Chairman, Peter Savas, Reviews Companys Progress in its Annual Letter to Stockholders
10. Alseres Pharmaceuticals to Host 2008 Second Quarter Conference Call
11. Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009).... 30 Jedi Mind, Inc . (...d to announce the Company,s first thought-controll...e game, "Think-Tac-Toe" is the first of its kind, ...wer of their mind and is geared towards people of ...of $49 and can be purchased directly through the C...
(Date:11/30/2009)...nd, Nov. 30 Tyco Interna...s 2010 annual general meeting of shareholders will... Central European time at the Park Hyatt Zurich Ho...d. Registered shareholders as of January 11, 2010 ...annual general meeting. Additionally, individuals...
(Date:11/30/2009)...tween the registration of a visual stimulus by the... it ― between the time we see an apple and t... behind our eyes, but by how long? And how does th..., Some estimates say the time delay lasts only 1...w study by Tel Aviv University psychologists says ...
(Date:11/30/2009)...ant results in animals , , MONDAY, Nov...s suggest that stem cells from transplanted human-... lung and heart disorders. , Scientists alread... a long list of different kinds of cells in the la... Center in Seoul, Korea, co-author of one of the s...
(Date:11/30/2009)...30 Kemin Foods, L.C. ("Kemin") and...ve Health Technologies, Ltd. ("OmniActive") have r...e parties agree that Kemin,s US Patent No. 5,382,7...on, Purification and Recrystallization of Lutein f..." and the reissues of that patent are valid and en...
Breaking Medicine News(10 mins):Health News:First Thought-Controlled Game Complete From Jedi Mind, Inc. 2Health News:Now you see it, now you know you see it 2
... Many people may not be aware that lifestyle ch... inactivity, puts them at a much greater risk for ...things you can start doing right away to reduce yo...ng as the sixth leading cause of death, with 125,0...
... Consistent increase in capital spending by pro...chinery, growing demand for reduction of downtime ...ueling the growth in smart sensors market. Global ...ks and smart sensors are being used widely in indu...
... Texas, Oct. 29 Unless you,re,portraying a wizene...ines,and pores may very well be holding you back, ... boss decides you are not conveying enough vim and...y,and depressed all of the time, and begins eyeing...
...h lower recurrence rates, study finds , , ...s, night sweats and joint symptoms in breast cance...f estrogen depletion or blockage and may point to ...r first follow-up visit during a trial assessing t...
...9 (Nasdaq: WHRTD ) --,World Heart Corporation (W...k split of 30-to-1 after filing of articles of ame...ess Corporations Act and commenced trading on,the ... at a Special Meeting of Shareholders held on Octo...
...ed For Wednesday, November 5, 2008 at 10:30 AM,ET,... ), a provider of functional foods, beverages and ...eport its third quarter financial,results for the ...0:30 AM ET, featuring Mr. John Pougnet, Chief,Exec...
Other Medicine News:Health News:Diabetes - Are You at Risk? Diet Company HMR Shares Top Strategy to Prevent or Delay Diabetes 2Health News:Global Market for Smart Sensors to Reach $7.8 Billion by 2015, According to a New Report by Global Industry Analysts, Inc. 2Health News:Global Market for Smart Sensors to Reach $7.8 Billion by 2015, According to a New Report by Global Industry Analysts, Inc. 3Health News:Economic Update: You Should Invest (in Your Appearance) 2Health News:Economic Update: You Should Invest (in Your Appearance) 3Health News:Hot Flashes, Night Sweats a Good Sign for Breast Cancer Patients 2Health News:WorldHeart Announces Effectiveness of Reverse Stock Split 2Health News:WorldHeart Announces Effectiveness of Reverse Stock Split 3Health News:XELR8 Holdings Announces Conference Call to Review Third Quarter Financial Results 2
(Date:11/30/2009)...LTON, Ill., Nov. 30 The Simmons la...edicated to representing thousands of women that w...he popular birth control pill manufactured and mar...icial Panel on Multidistrict Litigation has ordere...ll lawsuits be consolidated and centralized for pr...
(Date:11/30/2009)... WALTHAM, Mass., Nov. 30 According...thority on medical technology market intelligence,...market declined by almost 5% over 2008 as patients... the economic crisis. The market will, however, be...the strong pre-recession growth rates of over 15%....
(Date:11/30/2009)... BOZEN, Italy, November 30 Health...tation,s development plans and product specificati...Automated Parenteral,Nutrition", a new key compone...wcased at Las Vegas, ASHP (Booth # 114). , ...tomers to the,TPNstation,s blueprints and to find ...
Breaking Medicine Technology:Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer 2Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3HMS Awarded Third Party Liability Services Contract by Minnesota 57366 1Dr Drew and Drug Czar Host Online Chat 57362 1Pandesa ShareVault Enables Secure Real time Due Diligence for Biopharmaceutical Partnering 14096 1Pandesa ShareVault Enables Secure Real time Due Diligence for Biopharmaceutical Partnering 14096 2Pandesa ShareVault Enables Secure Real time Due Diligence for Biopharmaceutical Partnering 14096 3
...ab Reduced Hospitalizations Due to Respiratory ...-, HONOLULU, May 4 MedImmune today announced tha...m a MedImmune-sponsored,Phase 3 study involving mo...(MAb) that is being evaluated for its potential to...cytial virus (RSV) in high-risk pediatric,patients...
...lestone Payment- -Memory to Host Conference... BASEL, Switzerland, May 2 ,Memory Pharmaceuticals...,announced that Roche has exercised its option to ...ticals, lead nicotinic alpha-7 agonist drug,candid...sorders. Roche,s,exercise of its option for MEM 34...
Other Medicine Technology:Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting 2Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting 3Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting 4Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting 5Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454 2Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454 3Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454 4
...ed Comfort Pick one of our pipettors up and use i...tor positionsright where they should beeven if you...gonomically designed to help avoid repetitive stre...oductivity In The Palm Of Your Hand Start dispens...
...ed Comfort Pick one of our pipettors up and use i...tor positionsright where they should beeven if you...gonomically designed to help avoid repetitive stre...oductivity In The Palm Of Your Hand Start dispens...
...ed Comfort Pick one of our pipettors up and use i...tor positionsright where they should beeven if you...gonomically designed to help avoid repetitive stre...oductivity In The Palm Of Your Hand Start dispens...
Finnpipette BioControl Multichannel, 8 Channel 0.5-10ul
Medicine Products: